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Abstract
Purpose Human pigmented tissue-engineered skin sub-
stitutes represent an advanced therapeutic option to treat
skin defects. The inflammatory response is one of the major
factors determining integration and long-term survival of
such a graft in vivo. The aim of the present study was to
investigate the spatiotemporal distribution of host-derived
macrophage and granulocyte graft infiltration as well as
hypoxia-inducible factor 1 alpha (HIF-1-alpha) expression
in a (nu/nu) rat model.
Methods Keratinocytes, melanocytes, and fibroblasts
derived from human skin biopsies were isolated, cultured,
and expanded in vitro. Dermal fibroblasts were seeded into
collagen type I hydrogels that were subsequently covered
by keratinocytes and melanocytes in 5:1 ratio. These pig-
mented dermo-epidermal skin substitutes were transplanted
onto full-thickness skin wounds on the back of immuno-
incompetent rats and analyzed at early (1 and 3 weeks) and
late (6 and 12 weeks) stages of wound healing. The
expression of distinct inflammatory cell markers specific
for granulocytes (HIS48) or macrophages (CD11b, CD68),
as well as HIF-1-alpha were analyzed and quantified by
immunofluorescence microscopy.
Results Our data demonstrate that granulocytes infiltrate
the entire graft at 1 week post-transplantation. This was
followed by monocyte/macrophage recruitment to the graft
at 3–12 weeks. The macrophages were initially restricted
to the borders of the graft (early stages), and were then
found throughout the entire graft (late stages). We observed
a time-dependent decrease of macrophages. Only a few
graft-infiltrating granulocytes were found between
6–12 weeks, mostly at the graft borders. A heterogeneous
expression of HIF-1-alpha was observed at both early and
late wound healing stages.
Conclusions Our findings demonstrate the spatiotemporal
distribution of inflammatory cells in our transplants closely
resembles the one documented for physiological wound
healing.
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Introduction
Autologous split-thickness skin grafts represent the ‘‘gold
standard’’ treatment for covering skin defects. However,
they become limited in massive burns, i.e., when more than
about 60 % of the total body surface is injured [1].
A. S. Klar and S. Bo¨ttcher-Haberzeth authors contributed equally to
this paper.
A. S. Klar  S. Bo¨ttcher-Haberzeth  T. Biedermann 
K. Michalak  E. Reichmann
Tissue Biology Research Unit, University Children’s Hospital
Zurich, Zurich, Switzerland
A. S. Klar  S. Bo¨ttcher-Haberzeth  T. Biedermann 
K. Michalak  E. Reichmann  M. Meuli
Children’s Research Center, University Children’s Hospital
Zurich, Zurich, Switzerland
S. Bo¨ttcher-Haberzeth  M. Meuli (&)
Department of Surgery, University Children’s Hospital Zurich,
Zurich, Switzerland
e-mail: martin.meuli@kispi.uzh.ch
M. Kisiel
Surgical Center, Hospital in Enko¨ping, Enko¨ping, Sweden
123
Pediatr Surg Int (2014) 30:1257–1264
DOI 10.1007/s00383-014-3616-5
Therefore, in vitro cultured tissue-engineered dermo-epi-
dermal skin analogs have been developed by our group as a
potential alternative to conventional techniques [2–6].
Skin wound healing is a vital process for reestablishing
tissue integrity and homeostasis following disease or
injury. Yet, the role of immune cells in the early and late
phases of skin wound repair of tissue-engineered skin
analogs after transplantation has so far not been adequately
investigated. The healing of a skin wound is a complex
biological process that is subdivided into three phases:
inflammation, tissue formation, and maturation [7]. The
early stage of skin repair is mediated by the inflammatory
phase, which is characterized by an immediate influx of
polymorphonuclear leukocytes (granulocytes), followed by
subsequent invasion of blood monocytes, which then dif-
ferentiate into tissue macrophages [8–11]. Neutrophil
granulocytes combat invading microorganisms, remove
cellular debris, and secrete pro-inflammatory cytokines,
such as interleukins 1 alpha and beta (IL-a and b) and
tumor necrosis factor alpha (TNF-a) [12]. Clearly, neu-
trophils play an important role in wound healing by acti-
vating fibroblasts and keratinocytes [13]. Conversely,
neutrophil depletion in the early inflammatory phase has
been shown to delay cutaneous wound healing in older
animals [14].
Macrophages represent the second major fraction of
inflammatory cells recruited into the wound site. They are
indispensable for successful wound healing as they secrete
important cytokines, chemokines, and growth factors such
as platelet-derived growth factor and vascular endothelial
growth factor to initiate the formation of granulation tissue
[8]. Macrophages are present through all stages of the
repair process with an increase during the phase of
inflammation, a peak during the phase of tissue formation,
and a gradual decline during the maturation phase [15].
Previous findings have demonstrated a crucial role for
macrophages to achieve tissue homeostasis by exerting
specific functions during the distinct phases of skin repair
[16].
As a deeper skin injury is invariably also associated with
the interruption of local blood supply to the tissue, it
inevitably results in local hypoxia, which upregulates
hypoxia-inducible factor 1 alpha (HIF-1-alpha) signaling.
However, limited evidence is available regarding the
influence of the local hypoxic microenvironment on che-
motactic activity and migratory behavior of inflammatory
cells. Previous studies demonstrated the recruitment of
monocytes/macrophages and granulocytes from the circu-
lating blood to damaged tissues, where they accumulate
and terminally differentiate within ischemic/hypoxic sites
with high HIF-1-alpha expression [17–22].
In this experimental study, we wanted to investigate the
spatiotemporal distribution of host-derived macrophage
and granulocyte infiltration as well as HIF-1-alpha
expression in a rat model.
Materials and methods
Human skin samples
The study was conducted according to the ‘‘Declaration of
Helsinki Principles’’ and after permission by the Ethic
Commission of the Canton Zurich. Parents or adolescent
patients gave informed consent to use skin samples. Human
foreskins were obtained from patients 1–16 years of age and
were used for the isolation of human epidermal keratino-
cytes, melanocytes, and dermal fibroblasts. Tissue samples
for histological examination were embedded in OCT com-
pound (Sakura Finetek, Switzerland) and kept at -20 C.
Isolation and culturing of primary cells
Keratinocytes and fibroblasts were isolated and cultured as
described in Klar et al. [3], melanocytes as specified in
Bo¨ttcher-Haberzeth et al. [6].
Preparation of tissue-engineered skin analogs
The skin analogs were prepared as previously described
[23]. Briefly, 1 9 105 human dermal fibroblasts (passage
1–3) were mixed with rat collagen type I and cultured in
transwell cell culture plates in 6-well format containing
inserts with 3.0 lm pore-size membranes (BD Falcon,
Switzerland). These dermal substitutes were grown in
Dulbecco’s modified Eagle’s medium (DMEM, Invitrogen,
Switzerland) for five days, followed by a seeding of
7 9 105 keratinocytes and melanocytes (passage 1–3). The
skin analogs were cultured for one week in a 1:5 mix of
melanocyte (Promocell, Germany) and keratinocyte growth
medium (SFM, Invitrogen, Switzerland).
Transplantation of cultured dermo-epidermal skin
analogs
The surgical protocol was approved by the local Commit-
tee for Experimental Animal Research (permission number
76/2011). Immuno-incompetent female nu/nu rats, eight to
ten weeks old (Harlan Laboratories, The Netherlands),
were prepared and anesthetized as previously described
[23]. Skin analogs were transplanted onto full-thickness
skin defects created surgically on the backs of the rats.
Custom-made steel rings (diameter 2.6 cm) were sutured
into those skin wounds using non-absorbable polyester
sutures (Ethibond, Ethicon, USA) to protect skin analogs
from surrounding rat skin. Skin analogs were covered with
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a silicone foil (Silon-SES, BMS, USA), a polyurethane
sponge (Ligasano, Ligamed, Austria), and a tape as wound
dressing. Dressing changes and photographic documenta-
tions were performed weekly. After 1, 3, 6, and 12
(N = 3–5) weeks transplanted skin analogs were excised in
toto and processed for cryo-sections.
Immunohistochemical staining
Immunofluorescence staining was performed as described
in Klar et al. [3]. Rat macrophages (CD11b (anti-Integrin
aM), Santa Cruz, Germany) and/or granulocytes (HIS48,
Santa Cruz, Germany) were counterstained with human
fibroblasts of dermal compartment [CD90 (clone 5E10,
1:50, Dianova, Germany)]. HIF-1-alpha was stained by
anti-HIF-1-alpha antibody [(clone EP1215Y, 1:500, abcam,
Switzerland)]. Pictures of immunofluorescence staining
were taken with a DXM1200F digital camera connected to
a Nikon Eclipse TE2000-U inverted microscope. The
device is equipped with Hoechst 33342-, FITC-, and
TRITC-filter sets (Nikon AG, Switzerland; Software: Ni-
kon ACT-1 version 2.70). Images were processed with
Photoshop 7.0 (Adobe Systems Inc., Germany).
Rat macrophage and granulocyte quantification
Numbers of macrophages and granulocytes in skin analogs
were determined by counting CD11b and HIS48 positive
cells at the graft borders or in the central parts of skin
analogs (white dotted insets in Figs. 1, 2). The dermal
compartment of skin analogs was delineated by human
CD90 staining. Five random high-power fields at 10x or
20x magnification were counted in 3–5 different sections of
each skin analog 1, 3, 6, and 12 weeks post-transplantation
Fig. 1 Infiltration of rat
granulocytes into transplanted
tissue-engineered dermo-
epidermal skin analogs. a, c, e,
g Staining of rat granulocytes
(HIS48; red) at the borders and
b, d, f, h in the central parts of
skin analogs. a, b, c,
d Distribution of rat
granulocytes during early (1 and
3 weeks) and e, f, g, h late
wound healing stages (6 and
12 weeks) post-transplantation.
The human dermal
compartment is marked by
human CD90 staining (green).
An increased number of
infiltrating granulocytes was
observed mostly at the graft
borders; however, there was
also a pronounced increase in
HIS48 positive cells in the
central parts of the grafts
between 3–6 weeks. Cell nuclei
are stained with Hoechst (blue).
Scale bars 50 lm
Pediatr Surg Int (2014) 30:1257–1264 1259
123
(N = 3–5). Immune cell density was expressed as the
average total number of rat CD11b or HIS48 positive cells
counted in each skin analog per high-power field. All
results are reported as mean ± standard deviation (SD).
Statistical analysis was performed with GraphPad Prism
4.0 (Graph Pad software, La Jolla, CA, USA).
Results
Rat granulocyte infiltration during early and late wound
healing of transplanted skin analogs
To characterize the granulocyte infiltration in transplanted
skin analogs, we analyzed the expression of granulocyte
marker HIS48 present on basophils, eosinophils, and
neutrophils (Figs. 1, 3a). Quantitative evaluation revealed
that the number of granulocytes has markedly increased at
the border and center of grafts from weeks 1 to 3 after
transplantation (early wound healing stage) (Figs. 1a–d,
3a). Granulocyte infiltration decreased slightly at the graft
borders 6 post-transplantation, whereas it increased mark-
edly in the graft center (Figs. 1e, f, 3a). The graft borders
were still infiltrated by granulocytes 12 weeks after trans-
plantation, but only a few of them were still present in the
central parts of grafts (Figs. 1g, h, 3a).
Rat macrophage infiltration during early and late wound
healing of transplanted skin analogs
To assess the influx of macrophages during early (Figs. 2a–
d, 3b) and late (Figs. 2e–h, 3b) stages of wound repair, we
Fig. 2 Infiltration of rat
macrophages into transplanted
tissue-engineered dermo-
epidermal skin analogs. a, c, e,
g Staining of rat macrophages
with CD11b (red) at the borders
and b, d, f, h in the central parts
of skin analogs. a, b, c,
d Distribution of rat
macrophages during early (1
and 3 weeks) and e, f, g, h late
wound healing stages (6 and
12 weeks) post-transplantation.
The human dermal
compartment is marked by
human CD90 staining (green).
The borders of transplanted skin
analogs show markedly
enhanced macrophage
infiltration as compared to the
central parts. Cell nuclei are
stained with Hoechst (blue).
Scale bars 100 lm
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quantified the expression of macrophage cell markers
CD11b (Figs. 2, 3b) and CD68 (data not shown). Host-
derived macrophages positive for CD11b marker were
observed at the graft borders of skin analogs as early as
1 week after transplantation, but were absent in the graft
center (Figs. 2a, b, 3b). By 3 weeks post-transplantation,
the number of macrophages almost doubled at the graft
borders (Figs. 2c, 3b), but only a few CD11b? cells were
found in the central parts of the graft (Fig. 2d). Six weeks
after transplantation, grafts were densely infiltrated by
macrophages, which particularly accumulated at graft
borders (Figs. 2e, f, 3b). At 12 weeks post-transplantation,
only a moderate number of CD11b? cells were found in the
graft (Figs. 2g, h, 3b). The level of macrophages in skin
analogs was markedly increased at the graft borders when
compared to the graft centers at all time points investigated
(Figs. 2, 3b).
Expression of HIF-1-alpha at various wound healing
stages of transplanted skin analogs
As ischemia/hypoxia occurs inevitably in wounded tissue,
we analyzed HIF-1-alpha expression in skin analogs after
transplantation (Fig. 4). As revealed by the staining in
Fig. 4a, a‘, the highest level of HIF-1-alpha expression was
found at early stages of wound repair, namely at 1 and
3 weeks post-transplantation (Fig. 4a, a‘, data not shown),
whereas it decreased after six and again after 12 weeks.
Higher magnification in Fig. 4a‘ demonstrates that HIF-1-
alpha was strongly expressed by keratinocytes in all epi-
dermal layers and also partially in the dermal compartment
delineated by human CD90-staining. Furthermore, the rat
tissue surrounding the skin graft also stained positive for
HIF-1-alpha (Fig. 4a). The HIF-1-alpha expression level
decreased markedly in all skin analogs at later stages post-
transplantation from weeks 6 to 12 (data not shown,
Fig. 4b, b‘). As revealed in Fig. b‘, the hypoxic regions
were restricted to some keratinocytes and only a few cells
in the dermis.
Discussion
Here, we have examined the spatial and temporal distri-
bution of host-derived monocytes/macrophages and gran-
ulocytes in relation to oxygen gradients in transplanted
pigmented dermo-epidermal skin analogs of human origin.
Our findings provide evidence that granulocytes appear
faster and in higher numbers than monocytes/macrophages
during early wound healing of skin analogs. However, the
number of both inflammatory cell types decreased slowly
at later wound healing stages. A number of aspects call for
a detailed comment.
First, our study demonstrates that the early inflammatory
phase of skin graft healing in vivo is dominated by the
activation of the immune system and influx of polymor-
phonuclear neutrophils. These findings are similar to the
ones of earlier studies investigating the chain of events
following a trivial skin injury [24, 25]. This early inflam-
matory phase is essential for the clearance of bacteria and
cellular debris at the wound site [7, 8]. Second, we
observed a progressive increase in the number of granu-
locytes which peaked at 6 weeks post-transplantation and
decreased thereafter. However, most other studies looking
at skin healing, investigated wounds only up to 14 [26] or
21 days post-injury. [27]. Both of these studies found a
progressive decrease of granulocytes with time. However,
it is not possible to directly compare those results with our
Fig. 3 The quantification of rat granulocyte and macrophage density
in transplanted skin analogs. a Granulocyte (HIS48) density at the
graft borders (white bars) and in the central parts (black bars). The
number of granulocytes increased over time, with the lowest level at 1
and 3 weeks, and the highest between 6–12 weeks post-transplanta-
tion. b Macrophage (CD11b) density at the graft borders (white bars)
and in the central parts (black bars). An increased number of
macrophages were observed at the graft borders as compared to the
graft center. Table shows values as the mean (± SD) of total numbers
of rat granulocytes (a) or macrophages (b) counted per high-power
field (910 magnification). N = 5 for each group
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study due to different experimental time points, inflam-
matory cell markers, and animal models used for the ana-
lysis. Interestingly, Baskaran et al. [28] describe decreased
granulocyte recruitment in remote organs following a burn
injury, but a sustained granulocyte homing into the wound
site (rat model). These effects were independent of the burn
size. Our observation that we still detect granulocytes in
our skin analogs at later stages post-transplantation, espe-
cially at the graft borders, seems to be an analogous
phenomenon.
Influx of granulocytes after wounding is typically fol-
lowed by a subsequent infiltration of monocytes/macro-
phages [29, 30]. We detected only low numbers of
macrophages during the early wound healing phase
(1–3 weeks), with a peak at 6 weeks, and a marked
decrease at 12 weeks post-transplantation. Overall, the
number of macrophages was lower than the one of gran-
ulocytes. In addition, the majority of infiltrating macro-
phages were concentrated at the graft borders. These
findings are perfectly consistent with the sequence of
events observed during normal skin wound healing [15]. It
has been shown, that macrophages require a longer time to
become active in the inflamed tissue area than neutrophils
do. However, after several days to several weeks, the
macrophages are the dominating phagocytic cells within
the healing area and, in parallel, there is an increased bone
marrow production of new monocytes [31, 32]. This points
at the specific functions of macrophages recruited during
the different phases of skin repair after an injury as dem-
onstrated by Lucas et al. [16]. Their study shows that the
depletion of macrophages restricted to the early stage of
tissue repair (inflammatory phase) significantly reduced the
formation of vascularized granulation tissue and impaired
epithelialization [16]. In contrast, depletion of macro-
phages in the consecutive mid-stage phase (tissue forma-
tion) resulted in severe hemorrhage and delayed or absent
wound closure of the injured tissue [16].
Further, our study provides new insights into the rela-
tionship between macrophages/granulocyte infiltration and
HIF-1-alpha expression in a wound healing setting, i.e.,
engraftment of our tissue-engineered skin substitutes. As to
be expected, during the initial healing phase (1–3 weeks),
there was a high HIF-1-alpha expression as a reflection of
abnormally low tissue oxygenation. This ischemic/hypoxic
microenvironment is essential to stimulate angiogenesis
and regulate the early inflammatory cell recruitment as
myeloid cells sense low oxygen gradients and move along
them to migrate toward the areas of inflammation [33, 34].
We have previously demonstrated that the upper dermal
compartment of our skin analogs remains avascular for up
to 2 weeks after grafting with host vessel ingrowth starting
only at 1 week in the lower dermal compartment [3, 4].
This timeline corresponds well with the enhanced expres-
sion of HIF-1-alpha observed in our skin analogs between
Fig. 4 HIF-1-alpha expression
in transplanted skin analogs. a,
a‘, b, b‘ Cells expressing HIF-1-
alpha (green) are counterstained
with human CD90 (red) to mark
the human dermal compartment
of skin analogs. a‘, b‘ Insets
show a higher magnification of
a and b images, respectively.
Note the high expression of
HIF-1-alpha in all layers of the
epidermis, as wells as partially
in the dermis early after
transplantation (1 week) (white
arrows). In contrast, only
moderate numbers of HIF-1-
alpha expressing cells were
found in the epidermis (white
arrowheads) and dermis (white
arrows) at later stages
(12 weeks) post-transplantation.
Cell nuclei are stained with
Hoechst (blue). White dotted
lines indicate the dermo-
epidermal junction. Scale bars
50 lm
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1–3 weeks and its downregulation to reach normoxic levels
6–12 weeks post-transplantation, and it is paralleled by the
onset of the maturation phase that leads to complete skin
restoration in vivo. Our findings are in line with those of
several other studies: The group of Ninikoski et al. [35] has
also demonstrated extremely low oxygen tensions in a
rodent wound chamber model using a subcutaneously
implanted viscose cellulose sponge at the first and second
day post-injury, which steadily decreased to reach a min-
imum by days 5–7. Other investigators showed a sustained
hypoxia up to 14 days post-injury using subcutaneous
sponge-induced granulation tissue model in rats [36]. In a
study on anastomosis healing (rabbit aorta), normoxia was
reestablished 6 weeks post-injury, which is consistent with
our results [37].
In summary, this is, to the best of our knowledge, the
first study investigating the spatiotemporal distribution of
inflammatory cells and HIF-1-alpha expression as tissue
hypoxia parameter in a wound healing setting consisting of
transplanting tissue-engineered human skin substitutes.
This long-term in vivo assay reveals that, basically, wound
healing occurs in the classical and well described way. This
confirmatory knowledge has significant clinical implica-
tions with regard to the planned application of such labo-
ratory grown skin substitutes in patients.
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